Global Chronic Kidney Disease (CKD) Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Chronic Kidney Disease (CKD) Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Chronic Kidney Disease (CKD) Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Chronic Kidney Disease (CKD) Drugs by Country/Region, 2017, 2022 & 2028

2.2 Chronic Kidney Disease (CKD) Drugs Segment by Type

2.2.1 ACE Inhibitors

2.2.2 Angiotensin-II Receptor Blockers

2.2.3 Calcium Channel Blockers

2.2.4 Beta Blockers: BREVIBLOC, Bystolic

2.2.5 Others

2.3 Chronic Kidney Disease (CKD) Drugs Sales by Type

2.3.1 Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Chronic Kidney Disease (CKD) Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Chronic Kidney Disease (CKD) Drugs Sale Price by Type (2017-2022)

2.4 Chronic Kidney Disease (CKD) Drugs Segment by Application

2.4.1 Hospitals

2.4.2 Specialty Clinics

2.5 Chronic Kidney Disease (CKD) Drugs Sales by Application

2.5.1 Global Chronic Kidney Disease (CKD) Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Chronic Kidney Disease (CKD) Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Chronic Kidney Disease (CKD) Drugs Sale Price by Application (2017-2022)

3 Global Chronic Kidney Disease (CKD) Drugs by Company

3.1 Global Chronic Kidney Disease (CKD) Drugs Breakdown Data by Company

3.1.1 Global Chronic Kidney Disease (CKD) Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Company (2020-2022)

3.2 Global Chronic Kidney Disease (CKD) Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Chronic Kidney Disease (CKD) Drugs Revenue by Company (2020-2022)

3.2.2 Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Chronic Kidney Disease (CKD) Drugs Sale Price by Company

3.4 Key Manufacturers Chronic Kidney Disease (CKD) Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Chronic Kidney Disease (CKD) Drugs Product Location Distribution

3.4.2 Players Chronic Kidney Disease (CKD) Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Chronic Kidney Disease (CKD) Drugs by Geographic Region

4.1 World Historic Chronic Kidney Disease (CKD) Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Chronic Kidney Disease (CKD) Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Chronic Kidney Disease (CKD) Drugs Annual Revenue by Geographic Region

4.2 World Historic Chronic Kidney Disease (CKD) Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Chronic Kidney Disease (CKD) Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Chronic Kidney Disease (CKD) Drugs Annual Revenue by Country/Region

4.3 Americas Chronic Kidney Disease (CKD) Drugs Sales Growth

4.4 APAC Chronic Kidney Disease (CKD) Drugs Sales Growth

4.5 Europe Chronic Kidney Disease (CKD) Drugs Sales Growth

4.6 Middle East & Africa Chronic Kidney Disease (CKD) Drugs Sales Growth

5 Americas

5.1 Americas Chronic Kidney Disease (CKD) Drugs Sales by Country

5.1.1 Americas Chronic Kidney Disease (CKD) Drugs Sales by Country (2017-2022)

5.1.2 Americas Chronic Kidney Disease (CKD) Drugs Revenue by Country (2017-2022)

5.2 Americas Chronic Kidney Disease (CKD) Drugs Sales by Type

5.3 Americas Chronic Kidney Disease (CKD) Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Chronic Kidney Disease (CKD) Drugs Sales by Region

6.1.1 APAC Chronic Kidney Disease (CKD) Drugs Sales by Region (2017-2022)

6.1.2 APAC Chronic Kidney Disease (CKD) Drugs Revenue by Region (2017-2022)

6.2 APAC Chronic Kidney Disease (CKD) Drugs Sales by Type

6.3 APAC Chronic Kidney Disease (CKD) Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Chronic Kidney Disease (CKD) Drugs by Country

7.1.1 Europe Chronic Kidney Disease (CKD) Drugs Sales by Country (2017-2022)

7.1.2 Europe Chronic Kidney Disease (CKD) Drugs Revenue by Country (2017-2022)

7.2 Europe Chronic Kidney Disease (CKD) Drugs Sales by Type

7.3 Europe Chronic Kidney Disease (CKD) Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Chronic Kidney Disease (CKD) Drugs by Country

8.1.1 Middle East & Africa Chronic Kidney Disease (CKD) Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Chronic Kidney Disease (CKD) Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Chronic Kidney Disease (CKD) Drugs Sales by Type

8.3 Middle East & Africa Chronic Kidney Disease (CKD) Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Chronic Kidney Disease (CKD) Drugs

10.3 Manufacturing Process Analysis of Chronic Kidney Disease (CKD) Drugs

10.4 Industry Chain Structure of Chronic Kidney Disease (CKD) Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Chronic Kidney Disease (CKD) Drugs Distributors

11.3 Chronic Kidney Disease (CKD) Drugs Customer

12 World Forecast Review for Chronic Kidney Disease (CKD) Drugs by Geographic Region

12.1 Global Chronic Kidney Disease (CKD) Drugs Market Size Forecast by Region

12.1.1 Global Chronic Kidney Disease (CKD) Drugs Forecast by Region (2023-2028)

12.1.2 Global Chronic Kidney Disease (CKD) Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Chronic Kidney Disease (CKD) Drugs Forecast by Type

12.7 Global Chronic Kidney Disease (CKD) Drugs Forecast by Application

13 Key Players Analysis

13.1 Pfizer, Inc.

13.1.1 Pfizer, Inc. Company Information

13.1.2 Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Product Offered

13.1.3 Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer, Inc. Main Business Overview

13.1.5 Pfizer, Inc. Latest Developments

13.2 Amgen

13.2.1 Amgen Company Information

13.2.2 Amgen Chronic Kidney Disease (CKD) Drugs Product Offered

13.2.3 Amgen Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Amgen Main Business Overview

13.2.5 Amgen Latest Developments

13.3 Roche

13.3.1 Roche Company Information

13.3.2 Roche Chronic Kidney Disease (CKD) Drugs Product Offered

13.3.3 Roche Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Roche Main Business Overview

13.3.5 Roche Latest Developments

13.4 GlaxoSmithKline (GSK)

13.4.1 GlaxoSmithKline (GSK) Company Information

13.4.2 GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Product Offered

13.4.3 GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 GlaxoSmithKline (GSK) Main Business Overview

13.4.5 GlaxoSmithKline (GSK) Latest Developments

13.5 Allergan

13.5.1 Allergan Company Information

13.5.2 Allergan Chronic Kidney Disease (CKD) Drugs Product Offered

13.5.3 Allergan Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Allergan Main Business Overview

13.5.5 Allergan Latest Developments

13.6 AbbVie

13.6.1 AbbVie Company Information

13.6.2 AbbVie Chronic Kidney Disease (CKD) Drugs Product Offered

13.6.3 AbbVie Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 AbbVie Main Business Overview

13.6.5 AbbVie Latest Developments

13.7 Kissei Pharmaceutical Co., Ltd.

13.7.1 Kissei Pharmaceutical Co., Ltd. Company Information

13.7.2 Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Product Offered

13.7.3 Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Kissei Pharmaceutical Co., Ltd. Main Business Overview

13.7.5 Kissei Pharmaceutical Co., Ltd. Latest Developments

14 Research Findings and Conclusion

Table 1. Chronic Kidney Disease (CKD) Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Chronic Kidney Disease (CKD) Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of ACE Inhibitors

Table 4. Major Players of Angiotensin-II Receptor Blockers

Table 5. Major Players of Calcium Channel Blockers

Table 6. Major Players of Beta Blockers: BREVIBLOC, Bystolic

Table 7. Major Players of Others

Table 8. Global Chronic Kidney Disease (CKD) Drugs Sales by Type (2017-2022) & (K Units)

Table 9. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Type (2017-2022)

Table 10. Global Chronic Kidney Disease (CKD) Drugs Revenue by Type (2017-2022) & ($ million)

Table 11. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Type (2017-2022)

Table 12. Global Chronic Kidney Disease (CKD) Drugs Sale Price by Type (2017-2022) & (USD/Unit)

Table 13. Global Chronic Kidney Disease (CKD) Drugs Sales by Application (2017-2022) & (K Units)

Table 14. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Application (2017-2022)

Table 15. Global Chronic Kidney Disease (CKD) Drugs Revenue by Application (2017-2022)

Table 16. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Application (2017-2022)

Table 17. Global Chronic Kidney Disease (CKD) Drugs Sale Price by Application (2017-2022) & (USD/Unit)

Table 18. Global Chronic Kidney Disease (CKD) Drugs Sales by Company (2020-2022) & (K Units)

Table 19. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Company (2020-2022)

Table 20. Global Chronic Kidney Disease (CKD) Drugs Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Company (2020-2022)

Table 22. Global Chronic Kidney Disease (CKD) Drugs Sale Price by Company (2020-2022) & (USD/Unit)

Table 23. Key Manufacturers Chronic Kidney Disease (CKD) Drugs Producing Area Distribution and Sales Area

Table 24. Players Chronic Kidney Disease (CKD) Drugs Products Offered

Table 25. Chronic Kidney Disease (CKD) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Chronic Kidney Disease (CKD) Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 29. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share Geographic Region (2017-2022)

Table 30. Global Chronic Kidney Disease (CKD) Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Chronic Kidney Disease (CKD) Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 33. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Country/Region (2017-2022)

Table 34. Global Chronic Kidney Disease (CKD) Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Chronic Kidney Disease (CKD) Drugs Sales by Country (2017-2022) & (K Units)

Table 37. Americas Chronic Kidney Disease (CKD) Drugs Sales Market Share by Country (2017-2022)

Table 38. Americas Chronic Kidney Disease (CKD) Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Country (2017-2022)

Table 40. Americas Chronic Kidney Disease (CKD) Drugs Sales by Type (2017-2022) & (K Units)

Table 41. Americas Chronic Kidney Disease (CKD) Drugs Sales Market Share by Type (2017-2022)

Table 42. Americas Chronic Kidney Disease (CKD) Drugs Sales by Application (2017-2022) & (K Units)

Table 43. Americas Chronic Kidney Disease (CKD) Drugs Sales Market Share by Application (2017-2022)

Table 44. APAC Chronic Kidney Disease (CKD) Drugs Sales by Region (2017-2022) & (K Units)

Table 45. APAC Chronic Kidney Disease (CKD) Drugs Sales Market Share by Region (2017-2022)

Table 46. APAC Chronic Kidney Disease (CKD) Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Region (2017-2022)

Table 48. APAC Chronic Kidney Disease (CKD) Drugs Sales by Type (2017-2022) & (K Units)

Table 49. APAC Chronic Kidney Disease (CKD) Drugs Sales Market Share by Type (2017-2022)

Table 50. APAC Chronic Kidney Disease (CKD) Drugs Sales by Application (2017-2022) & (K Units)

Table 51. APAC Chronic Kidney Disease (CKD) Drugs Sales Market Share by Application (2017-2022)

Table 52. Europe Chronic Kidney Disease (CKD) Drugs Sales by Country (2017-2022) & (K Units)

Table 53. Europe Chronic Kidney Disease (CKD) Drugs Sales Market Share by Country (2017-2022)

Table 54. Europe Chronic Kidney Disease (CKD) Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Country (2017-2022)

Table 56. Europe Chronic Kidney Disease (CKD) Drugs Sales by Type (2017-2022) & (K Units)

Table 57. Europe Chronic Kidney Disease (CKD) Drugs Sales Market Share by Type (2017-2022)

Table 58. Europe Chronic Kidney Disease (CKD) Drugs Sales by Application (2017-2022) & (K Units)

Table 59. Europe Chronic Kidney Disease (CKD) Drugs Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Sales by Country (2017-2022) & (K Units)

Table 61. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Sales by Type (2017-2022) & (K Units)

Table 65. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Sales by Application (2017-2022) & (K Units)

Table 67. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Chronic Kidney Disease (CKD) Drugs

Table 69. Key Market Challenges & Risks of Chronic Kidney Disease (CKD) Drugs

Table 70. Key Industry Trends of Chronic Kidney Disease (CKD) Drugs

Table 71. Chronic Kidney Disease (CKD) Drugs Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Chronic Kidney Disease (CKD) Drugs Distributors List

Table 74. Chronic Kidney Disease (CKD) Drugs Customer List

Table 75. Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 76. Global Chronic Kidney Disease (CKD) Drugs Sales Market Forecast by Region

Table 77. Global Chronic Kidney Disease (CKD) Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Chronic Kidney Disease (CKD) Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 80. Americas Chronic Kidney Disease (CKD) Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Chronic Kidney Disease (CKD) Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 82. APAC Chronic Kidney Disease (CKD) Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Chronic Kidney Disease (CKD) Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Europe Chronic Kidney Disease (CKD) Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 88. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Chronic Kidney Disease (CKD) Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 92. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Chronic Kidney Disease (CKD) Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 95. Pfizer, Inc. Basic Information, Chronic Kidney Disease (CKD) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 96. Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Product Offered

Table 97. Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 98. Pfizer, Inc. Main Business

Table 99. Pfizer, Inc. Latest Developments

Table 100. Amgen Basic Information, Chronic Kidney Disease (CKD) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 101. Amgen Chronic Kidney Disease (CKD) Drugs Product Offered

Table 102. Amgen Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 103. Amgen Main Business

Table 104. Amgen Latest Developments

Table 105. Roche Basic Information, Chronic Kidney Disease (CKD) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 106. Roche Chronic Kidney Disease (CKD) Drugs Product Offered

Table 107. Roche Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 108. Roche Main Business

Table 109. Roche Latest Developments

Table 110. GlaxoSmithKline (GSK) Basic Information, Chronic Kidney Disease (CKD) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 111. GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Product Offered

Table 112. GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 113. GlaxoSmithKline (GSK) Main Business

Table 114. GlaxoSmithKline (GSK) Latest Developments

Table 115. Allergan Basic Information, Chronic Kidney Disease (CKD) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 116. Allergan Chronic Kidney Disease (CKD) Drugs Product Offered

Table 117. Allergan Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 118. Allergan Main Business

Table 119. Allergan Latest Developments

Table 120. AbbVie Basic Information, Chronic Kidney Disease (CKD) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 121. AbbVie Chronic Kidney Disease (CKD) Drugs Product Offered

Table 122. AbbVie Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 123. AbbVie Main Business

Table 124. AbbVie Latest Developments

Table 125. Kissei Pharmaceutical Co., Ltd. Basic Information, Chronic Kidney Disease (CKD) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 126. Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Product Offered

Table 127. Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 128. Kissei Pharmaceutical Co., Ltd. Main Business

Table 129. Kissei Pharmaceutical Co., Ltd. Latest Developments

List of Figures

Figure 1. Picture of Chronic Kidney Disease (CKD) Drugs

Figure 2. Chronic Kidney Disease (CKD) Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Chronic Kidney Disease (CKD) Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Chronic Kidney Disease (CKD) Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of ACE Inhibitors

Figure 10. Product Picture of Angiotensin-II Receptor Blockers

Figure 11. Product Picture of Calcium Channel Blockers

Figure 12. Product Picture of Beta Blockers: BREVIBLOC, Bystolic

Figure 13. Product Picture of Others

Figure 14. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Type in 2021

Figure 15. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Type (2017-2022)

Figure 16. Chronic Kidney Disease (CKD) Drugs Consumed in Hospitals

Figure 17. Global Chronic Kidney Disease (CKD) Drugs Market: Hospitals (2017-2022) & (K Units)

Figure 18. Chronic Kidney Disease (CKD) Drugs Consumed in Specialty Clinics

Figure 19. Global Chronic Kidney Disease (CKD) Drugs Market: Specialty Clinics (2017-2022) & (K Units)

Figure 20. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Application (2017-2022)

Figure 21. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Application in 2021

Figure 22. Chronic Kidney Disease (CKD) Drugs Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Company in 2021

Figure 24. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Geographic Region in 2021

Figure 26. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Region (2017-2022)

Figure 27. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Country/Region in 2021

Figure 28. Americas Chronic Kidney Disease (CKD) Drugs Sales 2017-2022 (K Units)

Figure 29. Americas Chronic Kidney Disease (CKD) Drugs Revenue 2017-2022 ($ Millions)

Figure 30. APAC Chronic Kidney Disease (CKD) Drugs Sales 2017-2022 (K Units)

Figure 31. APAC Chronic Kidney Disease (CKD) Drugs Revenue 2017-2022 ($ Millions)

Figure 32. Europe Chronic Kidney Disease (CKD) Drugs Sales 2017-2022 (K Units)

Figure 33. Europe Chronic Kidney Disease (CKD) Drugs Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Revenue 2017-2022 ($ Millions)

Figure 36. Americas Chronic Kidney Disease (CKD) Drugs Sales Market Share by Country in 2021

Figure 37. Americas Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Country in 2021

Figure 38. United States Chronic Kidney Disease (CKD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Chronic Kidney Disease (CKD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Chronic Kidney Disease (CKD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Chronic Kidney Disease (CKD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Chronic Kidney Disease (CKD) Drugs Sales Market Share by Region in 2021

Figure 43. APAC Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Regions in 2021

Figure 44. China Chronic Kidney Disease (CKD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Chronic Kidney Disease (CKD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Chronic Kidney Disease (CKD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Chronic Kidney Disease (CKD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Chronic Kidney Disease (CKD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Chronic Kidney Disease (CKD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Chronic Kidney Disease (CKD) Drugs Sales Market Share by Country in 2021

Figure 51. Europe Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Country in 2021

Figure 52. Germany Chronic Kidney Disease (CKD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Chronic Kidney Disease (CKD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Chronic Kidney Disease (CKD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Chronic Kidney Disease (CKD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Chronic Kidney Disease (CKD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Country in 2021

Figure 59. Egypt Chronic Kidney Disease (CKD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Chronic Kidney Disease (CKD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Chronic Kidney Disease (CKD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Chronic Kidney Disease (CKD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Chronic Kidney Disease (CKD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Chronic Kidney Disease (CKD) Drugs in 2021

Figure 65. Manufacturing Process Analysis of Chronic Kidney Disease (CKD) Drugs

Figure 66. Industry Chain Structure of Chronic Kidney Disease (CKD) Drugs

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles